期刊文献+

DNA甲基化标志在胃肠肿瘤中的临床应用

Clinical application of marker based on DNA methylation in gastrointestinal tumor
下载PDF
导出
摘要 DNA甲基化是高等真核生物中经常发生的现象,这种表观遗传学改变常发生在基因的启动子区域,并且不改变DNA序列和遗传密码,具有可逆性,在基因转录调控中发挥重要作用。已近知道抑癌基因和一些与正常细胞功能相关基因的转录失活与DNA甲基化有关,在胃肠肿瘤的发生,发展中起重要作用。随着对DNA甲基化的分子机制的进一步认识,以甲基化为基础的标志在临床的应用,尤其是肿瘤的防治,展现了广阔的前景。目前,这一标志及其相关技术在临床的应用涉及到诊断及治疗等方面,诸如患病风险评估、早期诊断、预后判定、复发监测、治疗反应监测和治疗计划的制定以及可作为治疗靶点等。就DNA甲基化肿瘤标志在胃肠肿瘤中的临床应用研究进展作一综述。 DNA methylation is a kind of ordinary pheonemena in eukaryote. This epigenetic modification is reversible, and it occurs often in the promoter region of genes without change of DNA sequence and genetic code, and plays an important role in the regulation of genetic transcription. As we have knowen that. DNA methylation is associated with transcriptional silencing of tumor suppressors or other genes important for normal cellular function and plays an important role in the develnpment of gastro intestinal tumor. With the increased knowledge of molecular mechanism of DNA methylation, the markers based on DNA methylation have got extensive research on the diagnosis and treatment of gastrointestinal tumor, such as risk appraisal, early diagnosis, prognosis assessment, recurrence monitoring, thera peutic reaction monitoring, target of therapy, etc. Here we: re view the advancement of clinical application of DNA methylation tumor marker for gastrointestinal tumor.
作者 齐翀 刘炳亚
出处 《中华肿瘤防治杂志》 CAS 2007年第8期628-630,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 DNA甲基化 肿瘤标记 生物学 胃肠肿瘤 综述文献 DNA methylationt tumor markers, biology gastrointestinal neoplasms review literature
  • 相关文献

参考文献22

  • 1Stephen B,Baylin,Joyce E.Ohm.Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction?[J].Nature Reviews Cancer,2006,6(2):107-116.
  • 2Esteller M.DNA methylation and cancer therapy:new developments and expectations[J].Curr Opin Oncol,2005,17(1):55-60.
  • 3Masafumi Murai,Minoru Toyota,Hiromu Suzuki,et al.Aberrant Methylation and silencing of the BNIP3 gene in colorectal and gastric cancer[J].Clin Cancer Res,2005,11(3):1021-1027.
  • 4Issa J P,Garcia-Manero G,Giles FJ,et al.Phase I study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2=-deoxycytidine (Decitabine)in hematopoietic malignancies[J].Blood,2004,103(5):1635-1640.
  • 5Esteller M,Herman J G.Generating mutations but providing chemosensitivity:the role of O6-methylguanine DNA methyltransferase in human cancer[J].Oncogene,2004,23(1):1-8.
  • 6Hiranuma C,Kawakami K,Oyama K,et al.Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer[J].Int J Mol Med,2004,13(3):413-417.
  • 7Chan M W,Chu E S,To K F,et al.Quantitative detection of methylated SOCS-1,a tumor suppressor gene,by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection[J].Biotechnol Lett,2004,26(16):1289-1293.
  • 8Sakamoto N,Terai T,Ajioka Y,et al.Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors[J].Oncogene,2004,23(55):8900-8907.
  • 9Laird P W.The power and the promise of DNA methylation markers[J].Nature Reviews Cancer,2003,3(4):1-15.
  • 10Cui H,Cruz-Correa M,Giardiello F M,et al.Loss of IGF2 imprinting:a potential marker of colorectal cancer risk[J].Science,2003,299(5613):1753-1755.

二级参考文献35

  • 1Hoos A,Nissan A,Stojadinovic A,et al.Tissue microarray molecular profiling of early,node-negative adenocarcinoma of the rectum:a comprehensive analysis[J].Clin Cancer Res,2002,8(12):3841-3849.
  • 2Ahmed N,Oliva K,Wang Y,et al.Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach[J].Proteomics,2003,3(3):288-298.
  • 3Liao L,Cheng D,Wang J,et al.Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection[J].J Biol Chem,2004,279(35):37061-37068.
  • 4Shekouh A R,Thompson C C,Prime W,et al.Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma[J].Proteomics,2003,3(10):1988-2001.
  • 5Hanash S.2-D or not 2-D-is there a future for 2-D gels in proteomics? Insights from York proteomic meeting[J].Proteomics,2002,1(5):635-637.
  • 6Hoving S,Gerrits B,Vashd H,et al.Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients[J].Proteomics,2002,2(2):127-134.
  • 7Lopez M F,Berggren K,ChernokalskayaE,et al.A comparison of silver stain and SYPRO Ruby Protein Gel Stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling[J].Electrophoresis,2000,21 (17):3673-3683.
  • 8Unlu M,Morgan M E,Minden J S.Difference gel electrophoresis:a single gel method for detecting changes in protein extracts[J].Electrophoresis,1997,18(11):2071-2077.
  • 9Alban A,David S O,Bjorkesten L,et al.A novel experimental design for comparative two-dimensional gel analysis:two-dimensional difference gel electrophoresis incorporating a pooled internal standard[J].Proteomics,2003,3 (1):36-44.
  • 10Bernhardt J,Buttner K,Scharf C,et al.Dual channel imaging of two-dimensional electropherograms in Bacillus subtilis[J].Electrophoresis,1999,20 (11):2225-2240.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部